Molecule for treating an inflammatory disorder

Discloses a nucleic acid molecule for use as a medicament, wherein said nucleic acid molecule is represented by a nucleotide sequence selected from the group consisting of: i. nucleotide sequences encoding a polypeptide comprising an amino acid sequence that has at least 50% sequence identity with t...

Full description

Saved in:
Bibliographic Details
Main Authors RAMIREZ GARCIA LAURA, SOTO ALVAREZ MANUEL, ROMÁN ESCUTIA MARTA, ALONSO BEDATE CARLOS, CARNÉS SÁNCHEZ JERÓNIMO
Format Patent
LanguageEnglish
Published 25.09.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Discloses a nucleic acid molecule for use as a medicament, wherein said nucleic acid molecule is represented by a nucleotide sequence selected from the group consisting of: i. nucleotide sequences encoding a polypeptide comprising an amino acid sequence that has at least 50% sequence identity with the amino acid sequence of SEQ ID NO:1, ii. nucleotide sequences comprising a nucleotide sequence that has at least 50% sequence identity with the nucleotide sequence of SEQ ID NO:2, iii. nucleotide sequences the complementary strand of which hybridises to a nucleic acid molecule of sequence of (i) or (ii) and iv. nucleotide sequences the sequences of which differs from the sequence of a nucleic acid molecule of (iii) due to the degeneracy of the genetic code; wherein the sequences are as defined in the complete specification.
Bibliography:Application Number: NZ20120617454